131 related articles for article (PubMed ID: 8971678)
1. Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs.
Smal J; Marvola M; Liljequist C; Happonen I
J Vet Pharmacol Ther; 1996 Dec; 19(6):482-7. PubMed ID: 8971678
[TBL] [Abstract][Full Text] [Related]
2. Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
Smal J; Haapala O; Marvola M; Kuusela S; Happonen I
J Vet Pharmacol Ther; 1995 Feb; 18(1):17-23. PubMed ID: 7752301
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects.
Yagi N; Kiuchi T; Satoh H; Terashima Y; Kenmotsu H; Sekikawa H; Takada M
Biol Pharm Bull; 1996 Apr; 19(4):616-22. PubMed ID: 8860970
[TBL] [Abstract][Full Text] [Related]
4. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a monolithic floating dosage form for furosemide.
Menon A; Ritschel WA; Sakr A
J Pharm Sci; 1994 Feb; 83(2):239-45. PubMed ID: 8169797
[TBL] [Abstract][Full Text] [Related]
6. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies.
Pan J; Lu W; Li C; Wang S; He L
Arch Pharm Res; 2010 Aug; 33(8):1209-16. PubMed ID: 20803124
[TBL] [Abstract][Full Text] [Related]
7. In vitro/in vivo evaluation of two series of TA-5707F controlled release matrix tablets prepared with hydroxypropyl methyl cellulose derivatives with entero-soluble or gel-formation properties.
Yamakita H; Maejima T; Osawa T
Biol Pharm Bull; 1995 Oct; 18(10):1409-16. PubMed ID: 8593447
[TBL] [Abstract][Full Text] [Related]
8. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations.
Ozdemir N; Ordu S; Ozkan Y
Drug Dev Ind Pharm; 2000 Aug; 26(8):857-66. PubMed ID: 10900542
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
Qureshi SA; McGilveray IJ
Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
[TBL] [Abstract][Full Text] [Related]
10. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
Turner S; Federici C; Hite M; Fassihi R
Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
[TBL] [Abstract][Full Text] [Related]
11. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets.
Yan G; Li H; Zhang R; Ding D
Drug Dev Ind Pharm; 2000 Jun; 26(6):681-6. PubMed ID: 10826117
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of dextromethorphan hydrobromide sustained release tablets.
Meyyanathan SN; Rajan S; Muralidaharan S; Siddaiah MK; Krishnaraj K; Suresh B
Drug Deliv; 2008 Sep; 15(7):429-35. PubMed ID: 18712620
[TBL] [Abstract][Full Text] [Related]
14. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
Ravi PR; Ganga S; Saha RN
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
[TBL] [Abstract][Full Text] [Related]
15. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
[TBL] [Abstract][Full Text] [Related]
16. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
[TBL] [Abstract][Full Text] [Related]
17. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of microcrystalline chitosans for gastro-retentive drug delivery.
Säkkinen M; Tuononen T; Jürjenson H; Veski P; Marvola M
Eur J Pharm Sci; 2003 Aug; 19(5):345-53. PubMed ID: 12907285
[TBL] [Abstract][Full Text] [Related]
19. Gastroretentive inorganic-organic hybrids to improve class IV drug absorption.
Perioli L; Pagano C
Int J Pharm; 2014 Dec; 477(1-2):21-31. PubMed ID: 25290811
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of gastroretentive norfloxacin floating tablets.
Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
